Recurrent leiomyosarcoma with de-differentiation to chondrosarcoma and osteosarcoma: a case report

Authors

  • Zara Summers Gold Coast University Hospital
  • Aemelia Melloy Department of Surgery, Gold Coast University Hospital, Australia
  • Eshwarshanker Jeyarajan Department of Surgery, Gold Coast University Hospital, Australia
  • Timothy Wills Department of Surgery, Gold Coast University Hospital, Australia
  • David Parker Department of Surgery, Gold Coast University Hospital, Australia
  • Leigh Rutherford Department of Surgery, Gold Coast University Hospital, Australia
  • Philip Townend Department of Surgery, Gold Coast University Hospital, Australia

DOI:

https://doi.org/10.18203/2349-2902.isj20210984

Keywords:

Leiomyosarcoma, Retroperitoneum, Chondrosarcoma, Osteosarcoma

Abstract

Leiomyosarcoma are a rare type of tumour of smooth muscle that can be found in the retroperitoneum. There is a paucity of reported data around dedifferentiation of leiomyosarcoma. Our case report describes de-differentiation of recurrent leiomyosarcoma into osteosarcoma and chondrosarcoma in a patient who had a local recurrence of his leiomyosarcoma. The recurrence is on a background of intermediate grade leiomyosarcoma of the retroperitoneum and he underwent his original resection in 2019 and included a right nephrectomy and right hemicolectomy. Our patient is currently undergoing radiotherapy and we will continue ongoing follow up for his progress.

Author Biography

Zara Summers, Gold Coast University Hospital

Surgical Registrar, Department of Surgery

References

Choi JH, Ro JY. Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach. Diagnostics (Basel). 2020;10(9).

Mantas D, Garmpis N, Polychroni D, Garmpi A, Damaskos C, Liakea A, Sypsa G, Kouskos E. Retroperitoneal sarcomas: from diagnosis to treatment. Case series and review of the literature. G Chir. 2020;41(1):18-33.

WHO Classification of Tumours. Soft Tissue and Bone Tumours. 2020. Available at: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours. Accessed on: 24 December 2020.

McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, et al. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013;20(7):2140-7.

Gronchi A, Palmerini E, Quagliuolo V, Martin Broto J, Lopez Pousa A, Grignani G, et al. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. J Clin Oncol. 2020;38(19):2178-86.

Caudle AS, Tepper JE, Calvo BF, Meyers MO, Goyal LK, Cance WG, Kim HJ. Complications associated with neoadjuvant radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol. 2007;14(2):577-82.

Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997;15(8):2832-9.

Bartlett EK, Roses RE, Meise C, Fraker DL, Kelz RR, Karakousis GC. Preoperative radiation for retroperitoneal sarcoma is not associated with increased early postoperative morbidity. J Surg Oncol. 2014;109(6):606-11.

Nicolas MM, Tamboli P, Gomez JA, Czerniak BA. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol. 2010;41(5):663-71.

Oda Y, Miyajima K, Kawaguchi K, Tamiya S, Oshiro Y, Hachitanda Y, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol. 2001;25(8):1030-8.

Thway K, Jones RL, Noujaim J, Zaidi S, Miah AB, Fisher C. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies. Adv Anat Pathol. 2016;23(1):30-40.

Evans HL, Soule EH, Winkelmann RK. Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of 30 cases formerly classified as well differentiated liposarcoma. Cancer. 1979;43(2):574-84.

Fukuda T, Ohnishi Y, Watanabe H, Kaneko H, Suzuki T. Dedifferentiated leiomyosarcoma of the intestinal tract: histological, ultrastructural and immunohistochemical examinations. Virchows Arch A Pathol Anat Histopathol. 1992;420(4):313-20.

Shimada S, Ishizawa T, Ishizawa K, Kamada K, Hirose T. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation. Virchows Arch. 2005;447(5):835-41.

Binh MB, Guillou L, Hostein I, Château MC, Collin F, Aurias A, et al. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas. Am J Surg Pathol. 2007;31(10):1557-66.

Chen E, O'Connell F, Fletcher CD. Dedifferentiated leiomyosarcoma: clinicopathological analysis of 18 cases. Histopathology. 2011;59(6):1135-43.

Cheng H, Miura JT, Lalehzari M, Rajeev R, Donahue AE, Bedi M, Gamblin TC, Turaga KK, Johnston FM. Neoadjuvant radiotherapy for retroperitoneal sarcoma: A systematic review. J Surg Oncol. 2016;113(6):628-34.

Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol. 1996;61(2):90-9.

Downloads

Published

2021-03-26

Issue

Vol. 8 No. 4 (2021): April 2021

Section

Case Reports